Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development.

Autor: Gleiter, CH, Aichele, G, Nilsson, E, Hengen, N, Antonin, KH, Bieck, PR
Zdroj: British Journal of Clinical Pharmacology; 1985, Vol. 20 Issue 1, p81-84, 4p
Abstrakt: The pharmacokinetics of CGP 15 210 G, a new 5-HT uptake inhibitor in poor and extensive metabolisers of debrisoquine, give indirect evidence of an association between its metabolism and polymorphic hydroxylation of the debrisoquine type. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index